Eline founded the MedTech scale-up NightBalance in 2009 with a new therapy for sleep apnea. NightBalance was acquired by Philips in May 2018. Currently, she is the CEO of Hybridize Therapeutics, a spin-off from the LUMC that develops RNA-based therapies for viral infections. Furthermore, she is a Operational Partner at Thuja Capital. Also, she holds a position as a member of the Supervisory Board of Livassured, a company that introduces a smart wearable that warns caretakers on epileptic seizures. Eline was nominated for several lists of female and/or tech entrepreneurs like Quote, Glamour, Viva, Opzij, Financieel Dagblad, Sprout, The Inspiring 50, World Women's Forum and 35 Innovators Under 35 by MIT (2018).